Juncell_Providing professional financial news and data related to Juncell, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Juncell Refiles HKEX Main Board Listing; Core Asset GC101 Is World’s First TIL Therapy Without Intensive Lymphodepletion Chemotherapy

Tags：

Juncell IPO refile listing application

2026-06-16

Finance
Shun Yuen Enterprise Group (01748.HK): Appointment of Tang Xuming as Executive Director
Finance
Hong Shing Cheong Resources (01850.HK): Supplementary Disclosure of Curriculum Vitae for Newly Appointed Independent Non-executive Director Huang Zhenguo
Finance
Hong Kong Credit Corporation (01273.HK): Profit Attributable to Shareholders Expected to Rise 40%–60% Year-on-Year
Finance
MINIEYE Innovation (02431.HK): Signs Procurement Deal for 1,000 Autonomous Logistics Vehicles and Long-Term Cooperation Agreement
Finance
Baixin International (00574.HK): Ma Qinghai Resigns as Executive Director and Chief Executive Officer
Finance
Regent Pacific Group (00575.HK): Senstend™ Approved for Marketing by National Medical Products Administration
Finance
Dongjiang Environment (00895.HK): Fulfils Guarantee Obligation of Approximately RMB1.1983 Million for Controlled Subsidiary Mianyang Dongjiang
Finance
CSPC Pharmaceutical Group (01093.HK): New Drug Application for Valsartan Levoamlodipine Maleate Tablets Accepted
Finance
Lisi Group Holdings (00526.HK): Annual Net Profit Expected to Be No Less Than RMB115 Million with Substantial Year-on-Year Growth
Finance
Bank of Qingdao (03866.HK): Liu Xiaoshu Elected as Employee Director of the 9th Board of Directors

Scan QR Code

Download App